Agilent Technologies, Inc. (0HAV.L) LSE

Currency In USD

AD

Agilent Technologies, Inc.

Address

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States of America (the)

Phone

800 227 9770

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

18000

First IPO Date

January 29, 2018

Key Executives

NameTitlePayYear Born
Padraig McDonnellChief Executive Officer, President & Director2.64M1972
Rodney GonsalvesVice President of Finance832,0801966
Angelica A. RiemannSenior VP & President of Agilent CrossLab Group1.12M1971
Michael BucknerSenior Vice President, Chief Legal Officer, & Secretary1.18MN/A
Simon MaySenior VP and President of Life Sciences & Diagnostics Markets Group1.63M1973
August SpechtSenior Vice President & Chief Technology Officer0N/A
Tejas Rajeev SavantVice President of Investor Relations0N/A
Meghan A. HensonSenior Vice President & Chief Human Resources Officer01970
Frederick SchwarzSenior VP, Chief Strategy & Corporate Development Officer0N/A
Tim DownsVP & Chief Accounting Officer01981
Adam S. ElinoffSenior Vice President, Chief Financial Officer & Principal Financial Officer01978
AD

Description

Agilent Technologies, Inc. is a global enterprise that develops and delivers specialized solutions primarily for the life sciences, diagnostics, and applied chemical industries. Within its Life Sciences and Applied Markets division, the company supplies a wide array of laboratory instrumentation. This includes diverse chromatography and mass spectrometry systems (such as liquid, gas, LC-MS, GC-MS, and ICP-MS), along with other analytical instruments like atomic absorption, microwave plasma-atomic emission, ICP-OES, and Raman spectroscopy. For cell analysis, Agilent provides plate-based assays, flow cytometers, real-time analyzers, imaging systems, and microplate readers. The segment also covers comprehensive laboratory software for information management and analytics, automated and robotic lab systems, dissolution testing solutions, vacuum pumps, and specialized measurement technologies. Its Diagnostics and Genomics segment focuses on genetic and diagnostic tools. It offers arrays crucial for various genetic analyses, such as DNA mutation detection, genotyping, gene copy number assessment, identification of gene rearrangements, DNA methylation profiling, gene expression analysis, and target enrichment for next-generation sequencing. This segment also delivers genetic data management and interpretation software, alongside producing synthesized oligonucleotides. Furthermore, it supplies immunohistochemistry, in situ hybridization, and H&E (hematoxylin and eosin) and special staining products. Consumables and software for nucleic acid sample quality control, reagents for turbidimetry and flow cytometry, and the development of liquid-based pharmacodiagnostics are also part of its portfolio. The Agilent CrossLab segment is dedicated to providing essential laboratory consumables, including GC and LC columns, sample preparation products, custom chemistries, and general instrument supplies. Additionally, it offers a comprehensive suite of services, encompassing startup support, operational assistance, training, compliance support, software-as-a-service (SaaS) solutions, asset management, and expert consultation. Agilent distributes its products through multiple channels, including direct sales, various distributors, resellers, manufacturer's representatives, and e-commerce platforms. Established in 1999, Agilent Technologies, Inc. maintains its corporate headquarters in Santa Clara, California.

AD